Diaspirin cross-linked hemoglobin infusion did not influence base deficit and lactic acid levels in two clinical trials of traumatic hemorrhagic shock patient resuscitation

Journal of Trauma - Injury, Infection and Critical Care

Volumn 68, Issue 5, 2010, Pages 1158-1171

  Sloan, Edward P ^a   Koenigsberg, Max D ^b   Philbin, Nora B ^c   Gao, Weihua ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b ADVOCATE ILLINOIS MASONIC MEDICAL CENTER   (United States)

^c NAVAL MEDICAL RESEARCH CENTER   (United States)

Author keywords

Base Deficit; Diaspirin cross linked hemoglobin; Lactate; Resuscitation; Traumatic hemorrhagic shock

Indexed keywords

DIASPIRIN CROSSLINKED HEMOGLOBIN; HEMOGLOBIN; LACTIC ACID; OXYGEN; SODIUM CHLORIDE;

ARTICLE; BLUNT TRAUMA; CLINICAL TRIAL; DISEASE ASSOCIATION; DISORDERS OF ACID BASE BALANCE; DRUG INFUSION; EMERGENCY WARD; EUROPEAN UNION; HEMOPERFUSION; HEMORRHAGIC SHOCK; HUMAN; LACTATE BLOOD LEVEL; MORTALITY; MULTICENTER STUDY; PRIORITY JOURNAL; RESUSCITATION; SIDE EFFECT; SURVIVAL RATE; TREATMENT RESPONSE; UNITED STATES;

ACIDOSIS, LACTIC; ADULT; ASPIRIN; EMERGENCY MEDICAL SERVICES; EMERGENCY TREATMENT; EUROPE; FLUID THERAPY; HEMOGLOBINS; HUMANS; LACTIC ACID; MULTICENTER STUDIES AS TOPIC; REGRESSION ANALYSIS; RESUSCITATION; SHOCK, HEMORRHAGIC; SHOCK, TRAUMATIC; SURVIVAL ANALYSIS; TREATMENT OUTCOME; UNITED STATES; WATER-ELECTROLYTE IMBALANCE; WOUNDS AND INJURIES;

EID: 77952258119     PISSN: 00225282     EISSN: 15298809     Source Type: Journal    
DOI: 10.1097/TA.0b013e3181bbfaac     Document Type: Article

References (78)

1. Moore EE, Cheng AM, Moore HB, Masuno T, Johnson JL. Hemoglobin-based oxygen carriers in trauma care: scientific rationale for the US multicenter prehospital trial. World J Surg. 2006;30:1247-1257.
2. Winslow RM. Current status of oxygen carriers ('blood substitutes'): 2006. Vox Sang. 2006;91:102-110.
3. Sloan EP. The clinical trials of diaspirin cross-linked hemoglobin (DCLHb) in severe traumatic hemorrhagic shock: the tale of two continents. Intensive Care Med. 2003;29:347-349.
4. Schubert A, O'Hara JF Jr, Przybelski RJ, et al. Effect of diaspirin crosslinked hemoglobin (DCLHb HemAssist) during high blood loss surgery on selected indices of organ function. Artif Cells Blood Substit Immobil Biotechnol. 2002;30:259-283.
5. Philbin N, Rice J, Gurney J, et al. A hemoglobin-based oxygen carrier, bovine polymerized hemoglobin (HBOC-201) versus hetastarch (HEX) in a moderate severity hemorrhagic shock swine model with delayed evacuation. Resuscitation. 2005;66:367-378.
6. Torres Filho IP, Spiess BD, Barbee RW, Ward KR, Oldenhof J, Pittman RN. Systemic responses to hemodilution after transfusion with stored blood and with a hemoglobin-based oxygen carrier. Anesth Analg. 2005;100:912-920.
7. Alayash AI. Oxygen therapeutics: can we tame haemoglobin? Nat Rev Drug Discov. 2004;3:152-159.
8. Bloomfield EL, Rady MY, Esfandiari S. A prospective trial of diaspirin cross-linked hemoglobin solution in patients after elective repair of abdominal aortic aneurysm. Mil Med. 2004;169:546-550.
9. Garrioch MA, McClure JH, Wildsmith JA. Haemodynamic effects of diaspirin crosslinked haemoglobin (DCLHb) given before abdominal aortic aneurysm surgery. Br J Anaesth. 1999;83:702-707.
10. Lamy ML, Daily EK, Brichant JF, et al. Randomized trial of diaspirin cross-linked hemoglobin solution as an alternative to blood transfusion after cardiac surgery. The DCLHb Cardiac Surgery Trial Collaborative Group. Anesthesiology. 2000;92:646-656.
11. Sakai H, Hara H, Yuasa M, et al. Molecular dimensions of Hb-based O (2) carriers determine constriction of resistance arteries and hypertension. Am J Physiol Heart Circ Physiol. 2000;279:H908-H915.
12. Saxena R, Wijnhoud AD, Carton H, et al. Controlled safety study of a hemoglobin-based oxygen carrier, DCLHb, in acute ischemic stroke. Stroke. 1999;30:993-996.
13. Przybelski RJ, Daily EK, Kisicki JC, Mattia-Goldberg C, Bounds MJ, Colburn WA. Phase I study of the safety and pharmacologic effects of diaspirin cross-linked hemoglobin solution. Crit Care Med. 1996;24:1993-2000.
14. Winslow RM. Cell-free oxygen carriers: scientific foundations, clinical development, and new directions. Biochim Biophys Acta. 2008;1784:1382-1386.
15. Schultz SC, Grady B, Cole F, Hamilton I, Burhop K, Malcolm DS. A role for endothelin and nitric oxide in the pressor response to diaspirin cross-linked hemoglobin. J Lab Clin Med. 1993;122:301-308.
16. Sloan EP, Koenigsberg M, Gens D, et al. Diaspirin cross-linked hemoglobin (DCLHb) in the treatment of severe traumatic hemorrhagic shock: a randomized controlled efficacy trial. JAMA. 1999;282:1857-1864.
17. Kerner T, Ahlers O, Veit S, Riou B, Saunders M, Pison U. DCL-Hb for trauma patients with severe hemorrhagic shock: the European "On-Scene" multicenter study. Intensive Care Med. 2003;29:378-385.
18. Sloan EP, Philbin NB, Koenigsberg MD, Gao W. The lack of consistent DCLHb infusion blood pressure effects in the US and EU Traumatic Hemorrhagic Shock Clinical Trials. Shock. Published ahead-of-print May 18, 2009.
19. Abramson D, Scalea TM, Hitchcock R, Trooskin SZ, Henry SM, Greenspan J. Lactate clearance and survival following injury. J Trauma. 1993;35:584-588.
20. Cairns CB, Moore FA, Haenel JB, et al. Evidence for early supply independent mitochondrial dysfunction in patients developing multiple organ failure after trauma. J Trauma. 1997;42:532-536.
21. Claridge JA, Crabtree TD, Pelletier SJ, Butler K, Sawyer RG, Young JS. Persistent occult hypoperfusion is associated with a significant increase in infection rate and mortality in major trauma patients. J Trauma. 2000;48:8-14;
22. Krishna G, Sleigh JW, Rahman H. Physiological predictors of death in exsanguinating trauma patients undergoing conventional trauma surgery. Aust N Z J Surg. 1998;68:826-829.
23. Rixen D, Siegel JH. Bench-to-bedside review: oxygen debt and its metabolic correlates as quantifiers of the severity of hemorrhagic and post-traumatic shock. Crit Care. 2005;9:441-453.
24. Zehtabchi S, Baron BJ. Utility of base deficit for identifying major injury in elder trauma patients. Acad Emerg Med. 2007;14:829-831.
25. Reynolds PS, Barbee RW, Ward KR. Lactate profiles as a resuscitation assessment tool in a rat model of battlefield hemorrhage resuscitation. Shock. 2008;30:48-54.
26. Paladino L, Sinert R, Wallace D, Anderson T, Yadav K, Zehtabchi S. The utility of base deficit and arterial lactate in differentiating major from minor injury in trauma patients with normal vital signs. Resuscitation. 2008;77:363-368.
27. Gutierrez G, Comignani P, Huespe L, et al. Central venous to mixed venous blood oxygen and lactate gradients are associated with outcome in critically ill patients. Intensive Care Med. 2008;34:1662-1668.
28. Schmelzer TM, Perron AD, Thomason MH, Sing RF. A comparison of central venous and arterial base deficit as a predictor of survival in acute trauma. Am J Emerg Med. 2008;26:119-123.
29. Handrigan MT, Bentley TB, Oliver JD, Tabaku LS, Burge JR, Atkins JL. Choice of fluid influences outcome in prolonged hypotensive resuscitation after hemorrhage in awake rats. Shock. 2005;23:337-343.
30. Stern S, Rice J, Philbin N, et al. Resuscitation with the hemoglobinbased oxygen carrier, HBOC-201, in a swine model of severe uncontrolled hemorrhage and traumatic brain injury. Shock. 2009;31:64-79.
31. Gurney J, Philbin N, Rice J, et al. A hemoglobin based oxygen carrier, bovine polymerized hemoglobin (HBOC-201) versus Hetastarch (HEX) in an uncontrolled liver injury hemorrhagic shock swine model with delayed evacuation. J Trauma. 2004;57:726-738.
32. Pape A, Kleen M, Kemming G, Meisner F, Meier J, Habler O. Fluid resuscitation from severe hemorrhagic shock using diaspirin crosslinked hemoglobin fails to improve pancreatic and renal perfusion. Acta Anaesthesiol Scand. 2004;48:1328-1337.
33. Schultz SC, Hamilton IN Jr, Malcolm DS. Use of base deficit to compare resuscitation with lactated Ringer's solution, haemaccel, whole blood, and diaspirin cross-linked hemoglobin following hemorrhage in rats. J Trauma. 1993;35:619-625.
34. Winslow RM. Cell-free oxygen carriers: scientific foundations, clinical development, and new directions. Biochim Biophys Acta. 2008;1784:1382-1386.
35. Natanson C, Kern SJ, Lurie P, Banks SM, Wolfe SM. Cell-free hemoglobin-based blood substitutes and risk of myocardial infarction and death: a meta-analysis. JAMA. 2008;299:2304-2312.
36. Spahn DR, Kocian R. Artificial O2 carriers: status in 2005. Curr Pharm Des. 2005;11:4099-4114.
37. Bone HG, Westphal M. The prospect of hemoglobin-based blood substitutes: still a long stony road to go. Crit Care Med. 2005;33:694-695.
38. Kim HW, Greenburg AG. Artificial oxygen carriers as red blood cell substitutes: a selected review and current status. Artif Organs. 2004;28:813-828.
39. Greenburg AG, Kim HW. Hemoglobin-based oxygen carriers. Crit Care. 2004;8(suppl 2): S61-S64.
40. Chang TM. Hemoglobin-based red blood cell substitutes. Artif Organs. 2004;28:789-794.
41. Reah G, Bodenham AR, Mallick A, Daily EK, Przybelski RJ. Initial evaluation of diaspirin cross-linked hemoglobin (DCLHb) as a vasopressor in critically ill patients. Crit Care Med. 1997;25:1480-1488.
42. Rice J, Philbin N, Handrigan M, et al. Vasoactivity of bovine polymerized hemoglobin (HBOC-201) in swine with traumatic hemorrhagic shock with and without brain injury. J Trauma. 2006;61:1085-1099.
43. Smani Y, Faivre B, Audonnet-Blaise S, Labrude P, Vigneron C. Hemoglobin-based oxygen carrier distribution inside vascular wall and arterial pressure evolution: is there a relationship? Eur Surg Res. 2005;37:1-8.
44. Buehler PW, Alayash AI. All hemoglobin-based oxygen carriers are not created equally. Biochim Biophys Acta. 2008;1784:1378-1381.
45. Alayash AI, D'Agnillo F, Buehler PW. First-generation blood substitutes: what have we learned? Biochemical and physiological perspectives. Expert Opin Biol Ther. 2007;7:665-675.
46. Alayash AI. Hemoglobin-based blood substitutes: oxygen carriers, pressor agents, or oxidants? Nat Biotechnol. 1999;17:545-549.
47. Winslow RM. Alphaalpha-crosslinked hemoglobin: was failure predicted by preclinical testing? Vox Sang. 2000;79:1-20.
48. Sauaia A, Moore FA, Moore EE, Norris JM, Lezotte DC, Hamman RF. Multiple organ failure can be predicted as early as 12 hours after injury. J Trauma. 1998;45:291-301;
49. Cerovic O, Golubovic V, Spec-Marn A, Kremzar B, Vidmar G. Relationship between injury severity and lactate levels in severely injured patients. Intensive Care Med. 2003;29:1300-1305.
50. Eberhard LW, Morabito DJ, Matthay MA, et al. Initial severity of metabolic acidosis predicts the development of acute lung injury in severely traumatized patients. Crit Care Med. 2000;28:125-131.
51. Rixen D, Siegel JH. Metabolic correlates of oxygen debt predict posttrauma early acute respiratory distress syndrome and the related cytokine response. J Trauma. 2000;49:392-403.
52. Rixen D, Raum M, Bouillon B, Lefering R, Neugebauer E; Arbeitsgemeinschaft "Polytrauma" of the Deutsche Gesellschaft fur Unfallchirurgie. Base deficit development and its prognostic significance in posttrauma critical illness: an analysis by the trauma registry of the Deutsche Gesellschaft fur unfallchirurgie. Shock. 2001;15:83-89.
53. 2 in Trauma Patients Trial Investigators. Tissue oxygen saturation predicts the development of organ dysfunction during traumatic shock resuscitation. J Trauma. 2007;62:44-54; discussion 54-55.
54. Baron JF. Blood substitutes. Haemoglobin therapeutics in clinical practice. Crit Care. 1999;3:R99-R102.
55. Carmichael FJ, Ali AC, Campbell JA, et al. A phase I study of oxidized raffinose cross-linked human hemoglobin. Crit Care Med. 2000;28:2283-2292.
56. Hill SE, Gottschalk LI, Grichnik K. Safety and preliminary efficacy of hemoglobin raffimer for patients undergoing coronary artery bypass surgery. J Cardiothorac Vasc Anesth. 2002;16:695-702.
57. Cheng DC, Mazer CD, Martineau R, et al. A phase II dose-response study of hemoglobin raffimer (Hemolink) in elective coronary artery bypass surgery. J Thorac Cardiovasc Surg. 2004;127:79-86.
58. Jahr JS, Moallempour M, Lim JC. HBOC-201, hemoglobin glutamer-250 (bovine), Hemopure (Biopure Corporation). Expert Opin Biol Ther. 2008;8:1425-1433.
59. Olofsson C, Nygards EB, Ponzer S, et al. A randomized, single-blind, increasing dose safety trial of an oxygen-carrying plasma expander (Hemospan) administered to orthopaedic surgery patients with spinal anaesthesia. Transfus Med. 2008;18:28-39.
60. Smani Y. Hemospan: a hemoglobin-based oxygen carrier for potential use as a blood substitute and for the potential treatment of critical limb ischemia. Curr Opin Investig Drugs. 2008;9:1009-1019.
61. Moore EE, Moore FA, Fabian TC, et al; Poly Heme Study Group. Human polymerized hemoglobin for the treatment of hemorrhagic shock when blood is unavailable: the USA multicenter trial. J Am Coll Surg. 2008;23:1-13.
62. D'Agnillo F, Alayash AI. Site-specific modifications and toxicity of blood substitutes. The case of diaspirin cross-linked hemoglobin. Adv Drug Deliv Rev. 2000;40:199-212.
63. 2 carriers. Biophys Chem. 2009;143:1-17.
64. Jia Y, Alayash AI. Effects of cross-linking and zero-link polymerization on oxygen transport and redox chemistry of bovine hemoglobin. Biochim Biophys Acta. 2009;1794:1234-1242.
65. Sperry JL, Ochoa JB, Gunn SR, et al; Inflammation the Host Response to Injury Investigators. An FFP:PRBC transfusion ratio >/=1:1.5 is associated with a lower risk of mortality after massive transfusion. J Trauma. 2008;65:986-993.
66. Sperry JL, Frankel HL, Vanek SL, et al. Early hyperglycemia predicts multiple organ failure and mortality but not infection. J Trauma. 2007;63:487-493; discussion 493-494.
67. Dutton RP, Mackenzie CF, Scalea TM. Hypotensive resuscitation during active hemorrhage: impact on in-hospital mortality. J Trauma. 2002;52:1141-1146.
68. Davis JW, Shackford SR, Mackersie RC, Hoyt DB. Base deficit as a guide to volume resuscitation. J Trauma. 1988;28:1464-1467.
69. Rutherford EJ, Morris JA Jr, Reed GW, Hall KS. Base deficit stratifies mortality and determines therapy. J Trauma. 1992;33:417-423.
70. Dunne JR, Tracy JK, Scalea TM, Napolitano LM. Lactate and base deficit in trauma: does alcohol or drug use impair their predictive accuracy? J Trauma. 2005;58:959-966.
71. Chang MC, Rutherford EJ, Morris JA Jr. Base deficit as a guide to injury severity and volume resuscitation. J Tenn Med Assoc. 1993;86:59-61.
72. Freilich D, Pearce LB, Pitman A, et al. HBOC-201 vasoactivity in a phase III clinical trial in orthopedic surgery subjects-extrapolation of potential risk for acute trauma trials. J Trauma. 2009;66:365-376.
73. Blow O, Magliore L, Claridge JA, Butler K, Young JS. The golden hour and the silver day: detection and correction of occult hypoperfusion within 24 hours improves outcome from major trauma. J Trauma. 1999;47:964-969.
74. Martin M, Murray J, Berne T, Demetriades D, Belzberg H. Diagnosis of acid-base derangements and mortality prediction in the trauma intensive care unit: the physiochemical approach. J Trauma. 2005;58:238-243.
75. Ivatury RR, Simon RJ, Havriliak D, Garcia C, Greenbarg J, Stahl WM. Gastric mucosal pH and oxygen delivery and oxygen consumption indices in the assessment of adequacy of resuscitation after trauma: a prospective, randomized study. J Trauma. 1995;39:128-134;
76. Manikis P, Jankowski S, Zhang H, Kahn RJ, Vincent JL. Correlation of serial blood lactate levels to organ failure and mortality after trauma. Am JEmerg Med. 1995;13:619-622.
77. Jahr JS, Osgood S, Rothenberg SJ, et al. Lactate measurement interference by hemoglobin-based oxygen carriers (Oxyglobin, Hemopure, and Hemolink). Anesth Analg. 2005;100:431-436.
78. Sloan EP, Weir B, Philbin N, Koenigsberg M. Shock index does not differ following the infusion of DCLHb in two clinical trials of traumatic hemorrhagic shock, such that its clinical use as a measure of compensated shock is valid. Ann Emerg Med. 2008;52:S109.